全文获取类型
收费全文 | 827篇 |
免费 | 33篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 30篇 |
妇产科学 | 15篇 |
基础医学 | 78篇 |
口腔科学 | 30篇 |
临床医学 | 79篇 |
内科学 | 152篇 |
皮肤病学 | 13篇 |
神经病学 | 21篇 |
特种医学 | 98篇 |
外科学 | 108篇 |
综合类 | 53篇 |
预防医学 | 48篇 |
眼科学 | 6篇 |
药学 | 67篇 |
中国医学 | 1篇 |
肿瘤学 | 81篇 |
出版年
2022年 | 7篇 |
2021年 | 8篇 |
2020年 | 6篇 |
2019年 | 11篇 |
2018年 | 22篇 |
2017年 | 8篇 |
2016年 | 10篇 |
2015年 | 11篇 |
2014年 | 18篇 |
2013年 | 30篇 |
2012年 | 16篇 |
2011年 | 28篇 |
2010年 | 34篇 |
2009年 | 28篇 |
2008年 | 24篇 |
2007年 | 42篇 |
2006年 | 50篇 |
2005年 | 22篇 |
2004年 | 29篇 |
2003年 | 21篇 |
2002年 | 17篇 |
2001年 | 15篇 |
2000年 | 15篇 |
1999年 | 9篇 |
1998年 | 29篇 |
1997年 | 34篇 |
1996年 | 38篇 |
1995年 | 23篇 |
1994年 | 14篇 |
1993年 | 23篇 |
1992年 | 12篇 |
1991年 | 10篇 |
1989年 | 22篇 |
1988年 | 12篇 |
1987年 | 18篇 |
1986年 | 14篇 |
1985年 | 12篇 |
1984年 | 14篇 |
1983年 | 9篇 |
1982年 | 7篇 |
1981年 | 6篇 |
1980年 | 15篇 |
1979年 | 11篇 |
1978年 | 5篇 |
1977年 | 9篇 |
1976年 | 7篇 |
1975年 | 9篇 |
1973年 | 13篇 |
1970年 | 4篇 |
1969年 | 4篇 |
排序方式: 共有881条查询结果,搜索用时 15 毫秒
1.
Coronary artery bypass grafts: visualization with MR imaging 总被引:1,自引:0,他引:1
2.
3.
4.
T J Whelan A J Dembo R S Bush J F Sturgeon S Fine J F Pringle G A Rawlings G M Thomas J Simm 《International journal of radiation oncology, biology, physics》1992,22(5):853-858
We examined the records of 105 patients with advanced ovarian cancer who had been treated with cisplatin combination chemotherapy followed by abdominopelvic radiotherapy. The purpose was to define the morbidity of this approach, and identify those factors predictive of toxicity. Acute toxicity resulting in delay or failure to complete treatment was most commonly due to myelosuppression. Nine of 105 patients (8.6%) required surgery for bowel obstruction that was not due to recurrent disease, 3 had an episode of bowel obstruction that settled conservatively, and a further 5 underwent surgery for obstruction due to recurrent tumor. The presence of both a dose of abdominopelvic radiotherapy over 2250 cGy, as well as a second-look laparotomy prior to radiotherapy, was associated with an increased risk of serious bowel complications. The increased frequency of late bowel morbidity seen in the combined modality group is likely explained by the presence of these two factors, rather than the exposure to chemotherapeutic agents per se. These observations are supported by the published literature. 相似文献
5.
6.
Ana Ortega Ph.D. George Dranitsaris M.Sci.Phm. Jeremy Sturgeon M.D. Heather Sutherland M.Sci. Amit Oza M.D. 《Gynecologic oncology》1997,66(3):454-463
The standard treatment for patients with advanced ovarian cancer (AOC) has been cyclophosphamide and cisplatin (CP). Recently, the results of a large randomized comparative trial demonstrated that the combination of paclitaxel and cisplatin (TP) provided a progression-free survival benefit of 5 months. In this study, a cost–utility analysis was performed from a Canadian health care system perspective to estimate the incremental cost-effectiveness of the TP combination. Twelve AOC patients who received treatment with TP were matched for age and disease stage on a 1-to-2 basis with a CP control. Total hospital resource consumption was then collected for all patients. Treatment preferences were estimated from a cohort of 20 patients and 40 healthy female volunteers using the time trade-off technique. The outcomes were then generated through a decision-analytic model. First-line treatment costs with TP were approximately fourfold greater on a per-cycle basis than the CP alternative (Can$1911 vs Can$459). When progression-free survival benefit and patient treatment preferences were incorporated into the analysis, the results of the decision model revealed an incremental cost between Can$12,000 and Can$24,000 per quality-adjusted progression-free year with the TP protocol. Even though the TP combination has a considerably higher drug acquisition cost, the results of the current analysis suggest that this new chemotherapy regimen does provide patients with substantial quality-adjusted progression-free survival benefit at a reasonable cost to the Canadian health care system. 相似文献
7.
8.
A W Fyles A J Dembo R S Bush W Levin L A Manchul J F Pringle G A Rawlings J F Sturgeon G M Thomas J Simm 《International journal of radiation oncology, biology, physics》1992,22(5):847-851
Between 1971 and 1985, 598 patients with ovarian carcinoma were treated with abdomino-pelvic radiation therapy. Acute complications included nausea and vomiting in 364 patients (61%) which were severe in 36, and diarrhea in 407 patients (68%), severe in 35. Leukopenia (less than 2.0 x 10(9) cells/liter) and thrombocytopenia (less than 100 x 10(9) cells/liter) occurred in 64 patients (11%) each. Treatment interruptions occurred in 136 patients (23%), and 62 patients (10%) did not complete treatment. In both situations the most common cause was myelosuppression. Late complications included chronic diarrhea in 85 patients (14%), transient hepatic enzyme elevation in 224 (44%), and symptomatic basal pneumonitis in 23 (4%). Serious late bowel complications were infrequent: 25 patients (4.2%) developed bowel obstruction and 16 required operation. Multivariate analysis was unable to determine any significant prognostic factors for bowel obstruction; however, the moving-strip technique of radiation therapy was associated with a significantly greater risk of developing chronic diarrhea, pneumonitis, and hepatic enzyme elevation than was the open beam technique. We conclude that abdomino-pelvic radiation therapy as used in these patients is associated with modest acute complications and a low risk of serious late toxicity. 相似文献
9.
Genotype-phenotype correlation for nucleotide substitutions in the IgII- IgIII linker of FGFR2 总被引:6,自引:3,他引:3
10.